Clinical Trial Update: A Study to Assess the Effect of a Single Dose of ASP8062 on the Multiple Dose Safety, Tolerability and Pharmacokinetics of Buprenorphine/Naloxone in Participants With Opioid Use Disorder [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the impact of a single dose of ASP8062 on the safety, tolerability, and pharmacokinetics of buprenorphine/naloxone in participants with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• ASP8062
• Buprenorphine/naloxone (buprenorphine/naloxone)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Opioid Use Disorder | Phase 1 | Status: COMPLETED | Results posted: 2022-01-12